Tag: Herceptin

Herceptin (trastuzumab): A monoclonal antibody used to treat HER2/neu overexpressing (HER2+) breast cancer. Herceptin works by binding to the HER2/neu receptor, thereby reducing the effects of overexpression of HER2.

Articles

News

05/01/16
Six-month delay in starting Herceptin linked to reduced survival in HER2+ breast cancer
05/23/15
Sulforaphane inhibits Herceptin-resistant Her2+ tumor growth and reduces triple negative breast cancer stem cell populations
07/22/12
Inflammation can contribute to resistance to Herceptin
05/13/12
A story of long-term stage IV HER2+ breast cancer survival
04/19/12
Green tea polyphenol EGCG slows development of tamoxifen resistance
12/13/11
Metformin improves survival of diabetic women with HER2+ breast cancer
12/01/11
Herceptin plus anthracycline chemotherapy greatly increases risk of heart damage
10/06/11
Non-anthracycline chemotherapy plus Herceptin is effective treatment for HER2+ breast cancer
09/22/11
Herceptin has reduced locoregional recurrence for HER2+ compared to triple negative breast cancer
03/19/11
Treatment with Herceptin for one year improves survival in women with HER2+ breast cancer
11/28/10
Erythropoietin for anemia may hinder Herceptin treatment for HER2-positive breast cancer
11/08/10
Response to neoadjuvant chemotherapy depends on dosage and tumor type
09/09/10
Flaxseed enhances Herceptin treatment in mouse model of HER2 breast cancer

Studies




Breast cancer resources | Definitions | Selected supplements and vitamins | Privacy policy | Search | Tags | Disclaimer/about us | Make a donation | Sitemap